{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T23:30:23Z","timestamp":1787959823352,"version":"build-2784847793"},"reference-count":29,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2007,1,1]],"date-time":"2007-01-01T00:00:00Z","timestamp":1167609600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,1,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>In oncogenic osteomalacia, the causative tumor is almost always difficult to find. A novel diagnostic approach is presented that facilitates a precise and rapid localization of the associated lesion by PET-CT co-registration using the radiotracer 68Ga-DOTANOC.<\/jats:p>\n               <jats:p>In oncogenic osteomalacia, the causative tumor is almost always difficult to find. A novel diagnostic approach is presented that facilitates a precise and rapid localization of the associated lesion by PET-CT co-registration using the radiotracer 68Ga-DOTANOC.<\/jats:p>\n               <jats:p>Introduction: Oncogenic osteomalacia (OOM) is an uncommon disorder characterized by hyperphosphaturia, hypophosphatemia, decreased vitamin D3 serum levels, and osteomalacia. The paraneoplastic syndrome is exclusively driven by a small somatostatin receptor (sst)-positive tumor that produces phosphatonins, proteins that cause renal phosphate loss. OOM can be cured completely on tumor removal. However, the exact tumor localization is the most challenging step, because the lesion is notoriously difficult to detect by common imaging techniques.<\/jats:p>\n               <jats:p>Materials and Methods: A 60-year-old woman complained of severe pain in her back and chest wall, muscle weakness, and reduced physical activity for &amp;gt;1 year. She suffered a metatarsal fracture and presented with hyperphosphaturia and hypophosphatemia. OOM was suspected, and a meticulous search for the tumor was initiated by conventional imaging techniques, sst-mediated imaging using 111In-octreotide scintigraphy, and 68Ga-DOTANOC-based positron emission tomography (PET)-CT co-registration. 68Ga-DOTANOC is a novel radiopharmaceutical compound in which the somatostatin analog octreotide is modified at position 3, chelated with DOTA, and complexed with 68Gallium. 68Ga-DOTANOC has an improved affinity to sst2 and sst5 relative to other radiopeptides.<\/jats:p>\n               <jats:p>Results: Whereas common imaging techniques such as CT failed to localize the tumor, 111In-octreotide scintigraphy was able to detect the lesion, but only PET-CT using 68Ga-DOTANOC revealed the exact tumor localization in the right femoral head. On tumor resection, the well being of the patient improved significantly, and biochemical parameters returned to normal.<\/jats:p>\n               <jats:p>Conclusions: 68Ga-DOTANOC-based PET-CT is a novel and powerful approach to detect sst-positive tumors in a timely manner and to provide highly resolved images facilitating the development of a therapeutic strategy.<\/jats:p>","DOI":"10.1359\/jbmr.060909","type":"journal-article","created":{"date-parts":[[2006,10,2]],"date-time":"2006-10-02T20:58:03Z","timestamp":1159822683000},"page":"158-162","source":"Crossref","is-referenced-by-count":63,"title":["Oncogenic Osteomalacia: Exact Tumor Localization by Co-Registration of Positron Emission and Computed Tomography"],"prefix":"10.1093","volume":"22","author":[{"given":"Eric","family":"Hesse","sequence":"first","affiliation":[{"name":"Department of Orthopaedics and Cell Biology, Yale University School of Medicine, New Haven, Connecticut, USA"},{"name":"Department of Trauma Surgery, Hannover Medical School, Hannover, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eckart","family":"Moessinger","sequence":"additional","affiliation":[{"name":"Department of Trauma Surgery, Hannover Medical School, Hannover, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herbert","family":"Rosenthal","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Radiology, Hannover Medical School, Hannover, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Laenger","sequence":"additional","affiliation":[{"name":"Institute of Pathology, Hannover Medical School, Hannover, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georg","family":"Brabant","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Hannover, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thorsten","family":"Petrich","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Hannover Medical School, Hannover, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus F","family":"Gratz","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Hannover Medical School, Hannover, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonard","family":"Bastian","sequence":"additional","affiliation":[{"name":"Department of Trauma Surgery, Hannover Medical School, Hannover, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2009,12,4]]},"reference":[{"key":"2024020319220867400_bib1","doi-asserted-by":"crossref","first-page":"F1170","DOI":"10.1152\/ajprenal.00072.2005","article-title":"\u201cPhosphatonins\u201d and the regulation of phosphorus homeostasis","volume":"289","author":"Berndt","year":"2005","journal-title":"Am J Physiol Renal Physiol"},{"key":"2024020319220867400_bib2","doi-asserted-by":"crossref","first-page":"3626","DOI":"10.1200\/JCO.2005.05.043","article-title":"Case 3. Oncogenic osteomalacia associated with hemangiopericytoma localized by octreotide scan","volume":"23","author":"Auethavekiat","year":"2005","journal-title":"J Clin Oncol"},{"key":"2024020319220867400_bib3","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/S0140-6736(02)07846-7","article-title":"Localisation of mesenchymal tumours by somatostatin receptor imaging","volume":"359","author":"Jan de Beur","year":"2002","journal-title":"Lancet"},{"key":"2024020319220867400_bib4","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s00264-001-0318-0","article-title":"Octreotide scanning in the detection of a mesenchymal tumour in the pubic symphysis causing hypophosphataemic osteomalacia","volume":"26","author":"Moran","year":"2002","journal-title":"Int Orthop"},{"key":"2024020319220867400_bib5","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1056\/NEJMoa010839","article-title":"Octreotide therapy for tumor-induced osteomalacia","volume":"345","author":"Seufert","year":"2001","journal-title":"N Engl J Med"},{"key":"2024020319220867400_bib6","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1046\/j.1365-2265.2001.01056.x","article-title":"Oncogenic osteomalacia associated with mesenchymal tumour detected by indium-111 octreotide scintigraphy","volume":"54","author":"Rhee","year":"2001","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2024020319220867400_bib7","first-page":"493","article-title":"A case of oncogenic osteomalacia detected by 111In-pentetreotide total body scan","volume":"21","author":"Casari","year":"2003","journal-title":"Clin Exp Rheumatol"},{"key":"2024020319220867400_bib8","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1097\/00003072-199902000-00016","article-title":"Indium-111 pentetreotide scintigraphy of mesenchymal tumor with oncogenic osteomalacia","volume":"24","author":"Nguyen","year":"1999","journal-title":"Clin Nucl Med"},{"key":"2024020319220867400_bib9","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1007\/s00259-004-1697-4","article-title":"68Ga-DOTANOC: A first compound for PET imaging with high affinity for somatostatin receptor subtypes 2 and 5","volume":"32","author":"Wild","year":"2005","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2024020319220867400_bib10","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1007\/s00259-003-1255-5","article-title":"DOTA-NOC, a high-affinity ligand of somatostatin receptor subtypes 2, 3 and 5 for labelling with various radiometals","volume":"30","author":"Wild","year":"2003","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2024020319220867400_bib11","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0140-6736(75)92736-1","article-title":"Nomogram for derivation of renal threshold phosphate concentration","volume":"2","author":"Walton","year":"1975","journal-title":"Lancet"},{"key":"2024020319220867400_bib12","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1172\/JCI18399","article-title":"FGF-23 in fibrous dysplasia of bone and its relationship to renal phosphate wasting","volume":"112","author":"Riminucci","year":"2003","journal-title":"J Clin Invest"},{"key":"2024020319220867400_bib13","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.bone.2005.01.001","article-title":"Oncogenic osteomalacia: Diagnostic importance of fibroblast growth factor 23 and F-18 fluorodeoxyglucose PET\/CT scan for the diagnosis and follow-up in one case","volume":"36","author":"Dupond","year":"2005","journal-title":"Bone"},{"key":"2024020319220867400_bib14","doi-asserted-by":"crossref","first-page":"4088","DOI":"10.1210\/jc.2002-021919","article-title":"Clinical case seminar: Fibroblast growth factor 23: A new clinical marker for oncogenic osteomalacia","volume":"88","author":"Nelson","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"2024020319220867400_bib15","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1007\/s00259-004-1486-0","article-title":"68Ga-labelled DOTA-derivatised peptide ligands","volume":"31","author":"Meyer","year":"2004","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2024020319220867400_bib16","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1148\/radiology.189.3.8234714","article-title":"Standardized uptake values of normal tissues at PET with 2-[fluorine-18]-fluoro-2-deoxy-D-glucose: Variations with body weight and a method for correction","volume":"189","author":"Zasadny","year":"1993","journal-title":"Radiology"},{"key":"2024020319220867400_bib17","first-page":"463","article-title":"Hypophosphatemic osteomalacia with plantar neurilemoma. A review of the literature (100 cases)","volume":"62","author":"Crouzet","year":"1995","journal-title":"Rev Rhum Engl Ed"},{"key":"2024020319220867400_bib18","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1017\/S0022215100140551","article-title":"Oncogenic osteomalacia: Case report and review of head and neck associated tumours","volume":"112","author":"Gonzalez-Compta","year":"1998","journal-title":"J Laryngol Otol"},{"key":"2024020319220867400_bib19","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/j.1750-3639.2004.tb00505.x","article-title":"August 2003: 47-year-old female with a 7-year history of osteomalacia and hypophosphatemia","volume":"14","author":"Reis-Filho","year":"2004","journal-title":"Brain Pathol"},{"key":"2024020319220867400_bib20","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1023\/A:1006352106762","article-title":"Craniofacial hemangiopericytoma associated with oncogenic osteomalacia: Case report","volume":"46","author":"Sandhu","year":"2000","journal-title":"J Neurooncol"},{"key":"2024020319220867400_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00000478-200401000-00001","article-title":"Most osteomalacia-associated mesenchymal tumors are a single histopathologic entity: An analysis of 32 cases and a comprehensive review of the literature","volume":"28","author":"Folpe","year":"2004","journal-title":"Am J Surg Pathol"},{"key":"2024020319220867400_bib22","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1056\/NEJMe030037","article-title":"Oncogenic osteomalacia\u2013a complex dance of factors","volume":"348","author":"Carpenter","year":"2003","journal-title":"N Engl J Med"},{"key":"2024020319220867400_bib23","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1056\/NEJMoa020881","article-title":"Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia","volume":"348","author":"Jonsson","year":"2003","journal-title":"N Engl J Med"},{"key":"2024020319220867400_bib24","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.jbspin.2004.02.006","article-title":"Somatostatin and somatostatin analog scintigraphy: Any benefits for rheumatology patients?","volume":"71","author":"Duet","year":"2004","journal-title":"Joint Bone Spine"},{"key":"2024020319220867400_bib25","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1055\/s-2005-837403","article-title":"[Oncogenic osteomalacia in a 49-year-old female patient]","volume":"130","author":"Ludwig","year":"2005","journal-title":"Dtsch Med Wochenschr"},{"key":"2024020319220867400_bib26","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1007\/s002590100541","article-title":"Somatostatin receptor sst1-sst5 expression in normal and neoplastic human tissues using receptor autoradiography with subtype-selective ligands","volume":"28","author":"Reubi","year":"2001","journal-title":"Eur J Nucl Med"},{"key":"2024020319220867400_bib27","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1007\/s00330-006-0183-8","article-title":"Whole-body MRI and PET-CT in the management of cancer patients","volume":"16","author":"Schmidt","year":"2006","journal-title":"Eur Radiol"},{"key":"2024020319220867400_bib28","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.tem.2005.11.005","article-title":"Staging and treatment of differentiated thyroid carcinoma with radiolabeled somatostatin analogs","volume":"17","author":"Teunissen","year":"2006","journal-title":"Trends Endocrinol Metab"},{"key":"2024020319220867400_bib29","first-page":"62S","article-title":"Overview of results of peptide receptor radionuclide therapy with 3 radiolabeled somatostatin analogs","volume":"46","author":"Kwekkeboom","year":"2005","journal-title":"J Nucl Med"}],"container-title":["Journal of Bone and Mineral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1359%2Fjbmr.060909","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/22\/1\/158\/56550350\/5650220119.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/22\/1\/158\/56550350\/5650220119.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,13]],"date-time":"2024-03-13T14:47:45Z","timestamp":1710341265000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jbmr\/article\/22\/1\/158-162\/7597124"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,1,1]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2009,12,4]]},"published-print":{"date-parts":[[2007,1,1]]}},"URL":"https:\/\/doi.org\/10.1359\/jbmr.060909","relation":{},"ISSN":["0884-0431","1523-4681"],"issn-type":[{"value":"0884-0431","type":"print"},{"value":"1523-4681","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2007,1,1]]},"published":{"date-parts":[[2007,1,1]]}}}